Scott Widmann, Ph.D. is a Postdoctoral Research Scientist II in the Department of Pharmaceutical Sciences at Texas Southern University. With a strong background in cancer biology, drug discovery, and computational biology, Dr. Widmann focuses on incorporating artificial intelligence (AI) and machine learning (ML) techniques in the drug discovery process. His research investigates novel therapeutics for cancer and infectious diseases. In addition to his research, Dr. Widmann mentors students in computational biology and drug discovery, and he is passionate about promoting interdisciplinary collaboration to drive innovation in drug discovery.